(Reuters) – A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend a booster dose of Moderna Inc’s COVID-19 vaccine for people age 65 and older, and some high-risk individuals.
(Reporting by Manas Mishra in Bengaluru; Editing by Chris Reese)
